BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34751412)

  • 1. Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca
    Bian Y; Yu H; Jin M; Gao X
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34751412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.
    Goldstein NB; Koster MI; Jones KL; Gao B; Hoaglin LG; Robinson SE; Wright MJ; Birlea SI; Luman A; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2018 Mar; 138(3):657-668. PubMed ID: 29054607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
    Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin pigmentation and its control: From ultraviolet radiation to stem cells.
    Yardman-Frank JM; Fisher DE
    Exp Dermatol; 2021 Apr; 30(4):560-571. PubMed ID: 33320376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2012; 78(2):159-64. PubMed ID: 22421646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.
    Arowojolu OA; Orlow SJ; Elbuluk N; Manga P
    Exp Dermatol; 2017 Jul; 26(7):637-644. PubMed ID: 28370349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling.
    Goldstein NB; Steel A; Barbulescu CC; Koster MI; Wright MJ; Jones KL; Gao B; Ward B; Woessner B; Trottier Z; Pakieser J; Hu J; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2021 Mar; 141(3):638-647.e13. PubMed ID: 32800877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repigmentation through Melanocyte Regeneration in Vitiligo.
    Birlea SA; Goldstein NB; Norris DA
    Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.
    Goldstein NB; Koster MI; Hoaglin LG; Wright MJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    Exp Dermatol; 2016 Oct; 25(10):805-11. PubMed ID: 27193292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of autologous micrografts on stable bilateral vitiligo: A focus on hand lesions.
    Menchini G; Astarita C
    J Dermatol; 2020 Dec; 47(12):1417-1423. PubMed ID: 32954507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.
    Ma J; Li S; Zhu L; Guo S; Yi X; Cui T; He Y; Chang Y; Liu B; Li C; Jian Z
    Free Radic Biol Med; 2018 Dec; 129():492-503. PubMed ID: 30342186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
    Bansal S; Sahoo B; Garg V
    Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
    Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
    Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
    Natta R; Somsak T; Wisuttida T; Laor L
    J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
    Yu S; Lan CE; Yu HS
    Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and vitiligo: the Nrf2-ARE signaling connection.
    Qiu L; Song Z; Setaluri V
    J Invest Dermatol; 2014 Aug; 134(8):2074-2076. PubMed ID: 25029322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.